{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:43:00Z","timestamp":1788525780207,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.biologicals.2021.01.001","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T20:22:43Z","timestamp":1611865363000},"page":"53-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Saccharide dosage content of meningococcal polysaccharide conjugate vaccines determined using WHO International Standards for serogroup A, C, W, Y and X polysaccharides"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6096-5339","authenticated-orcid":false,"given":"Fang","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1314-5076","authenticated-orcid":false,"given":"Kay","family":"Lockyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karena","family":"Burkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rigsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bolgiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12 Suppl","key":"10.1016\/j.biologicals.2021.01.001_bib1","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1097\/01.inf.0000147642.85129.05","article-title":"Global epidemiology of meningococcal disease and vaccine efficacy","volume":"23","author":"Pollard","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.biologicals.2021.01.001_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/2047773214Y.0000000126","article-title":"Global practices of meningococcal vaccine use and impact on invasive disease","volume":"108","author":"Ali","year":"2014","journal-title":"Pathog Glob Health"},{"issue":"Suppl 5","key":"10.1016\/j.biologicals.2021.01.001_bib3","doi-asserted-by":"crossref","first-page":"S396","DOI":"10.1093\/cid\/civ594","article-title":"The evolution of the meningitis vaccine project","volume":"61","author":"Tiffay","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2021.01.001_bib4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1186\/s12879-014-0663-4","article-title":"Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine","volume":"14","author":"Kristiansen","year":"2014","journal-title":"MenAfriVac. BMC Infect Dis."},{"issue":"12","key":"10.1016\/j.biologicals.2021.01.001_bib5","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1017\/S0950268814001149","article-title":"Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America","volume":"142","author":"Abad","year":"2014","journal-title":"Epidemiol Infect"},{"issue":"13","key":"10.1016\/j.biologicals.2021.01.001_bib6","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.vaccine.2016.02.014","article-title":"Global epidemiology of capsular group W meningococcal disease (1970-2015): multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex","volume":"34","author":"Mustapha","year":"2016","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.biologicals.2021.01.001_bib7","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.vaccine.2017.03.007","article-title":"The epidemiology of invasive meningococcal disease in EU\/EEA countries, 2004-2014","volume":"35","author":"Whittaker","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2021.01.001_bib8","series-title":"Defeating meningitis by 2030: a global road map","year":"2020"},{"issue":"5","key":"10.1016\/j.biologicals.2021.01.001_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.biologicals.2012.03.003","article-title":"Evaluation of a candidate international standard for meningococcal group C polysaccharide","volume":"40","author":"Vipond","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2021.01.001_bib11","author":"Evaluation of candidate International Standards for Meningococcal Serogroups"},{"key":"10.1016\/j.biologicals.2021.01.001_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biologicals.2017.03.001","article-title":"Evaluation of candidate international standards for meningococcal serogroups A and X polysaccharide","volume":"47","author":"Vipond","year":"2017","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2021.01.001_bib14","series-title":"WHO manual for the establishment of national and other secondary standards for vaccines","year":"2011"},{"issue":"29","key":"10.1016\/j.biologicals.2021.01.001_bib15","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1016\/j.vaccine.2019.05.050","article-title":"O-acetylation of typhoid capsular polysaccharide confers polysaccharide rigidity and immunodominance by masking additional epitopes","volume":"37","author":"Hitri","year":"2019","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.biologicals.2021.01.001_bib16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0264-410X(00)00261-9","article-title":"Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines","volume":"19","author":"Ho","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biologicals.2021.01.001_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1042\/BA20000078","article-title":"Solution stability studies of the subunit components of meningococcal C oligosaccharide-CRM197 conjugate vaccines","volume":"33","author":"Ho","year":"2001","journal-title":"Biotechnol Appl Biochem"},{"issue":"28","key":"10.1016\/j.biologicals.2021.01.001_bib18","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1016\/j.vaccine.2017.03.066","article-title":"Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM197, DT and TT glycoconjugate vaccines","volume":"35","author":"Beresford","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2021.01.001_bib19","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0264-410X(94)90219-4","article-title":"Quantification of polysaccharide in Haemophilus influenzae type b conjugate and polysaccharide vaccines by high-performance anion-exchange chromatography with pulsed amperometric detection","volume":"12","author":"Tsai","year":"1994","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.biologicals.2021.01.001_bib21","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.vaccine.2013.05.098","article-title":"Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimisation of hydrolysis conditions and chromatographic methods","volume":"31","author":"Cook","year":"2013","journal-title":"Vaccine"},{"issue":"15\u201316","key":"10.1016\/j.biologicals.2021.01.001_bib22","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0264-410X(00)00427-8","article-title":"Development of a new method for the quantitative analysis of the extracellular polysaccharide of Neisseria meningitidis serogroup A by use of high-performance anion-exchange chromatography with pulsed-amperometric detection","volume":"19","author":"Ricci","year":"2001","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.biologicals.2021.01.001_bib23","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1021\/ac5003933","article-title":"Quantification of each serogroup polysaccharide of Neisseria meningitidis in A\/C\/Y\/W-135-DT conjugate vaccine by high-performance anion-exchange chromatography-pulsed amperometric detection analysis","volume":"86","author":"Gudlavalleti","year":"2014","journal-title":"Anal Chem"},{"issue":"49","key":"10.1016\/j.biologicals.2021.01.001_bib24","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1016\/j.vaccine.2020.10.017","article-title":"Quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) using sandwich ELISA","volume":"38","author":"Phugare","year":"2020","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biologicals.2021.01.001_bib25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/2472630319890309","article-title":"Vaccine quality ensured by high-performance anion-exchange chromatography with pulsed amperometric detection","volume":"25","author":"Rohrer","year":"2020","journal-title":"SLAS Technol"},{"issue":"19\u201320","key":"10.1016\/j.biologicals.2021.01.001_bib26","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(02)00183-4","article-title":"Development of a high-performance anion-exchange chromatography with pulsed-amperometric detection based quantification assay for pneumococcal polysaccharides and conjugates","volume":"20","author":"Talaga","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2021.01.001_bib27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0003-2697(92)90349-C","article-title":"Carbohydrate composition analysis of bacterial polysaccharides: optimized acid hydrolysis conditions for HPAEC-PAD analysis","volume":"201","author":"Ip","year":"1992","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biologicals.2021.01.001_bib28","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/S0264-410X(99)00535-6","article-title":"Quantitative determination of saccharide in Haemophilus influenzae type b glycoconjugate vaccines, alone and in combination with DPT, by use of high-performance anion-exchange chromatography with pulsed amperometric detection","volume":"18","author":"Bardotti","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2021.01.001_bib29","first-page":"44","article-title":"Collaborative study on saccharide quantification of the Haemophilus influenzae type b component in liquid vaccine presentations","volume":"2017","author":"Rosskopf","year":"2017","journal-title":"Pharmeur Bio Sci Notes"},{"issue":"11","key":"10.1016\/j.biologicals.2021.01.001_bib30","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1021\/ac60119a033","article-title":"Microdetermination of phosphorus","volume":"28","author":"Chen","year":"1956","journal-title":"Anal Chem"},{"issue":"7","key":"10.1016\/j.biologicals.2021.01.001_bib31","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1128\/IAI.70.7.3707-3713.2002","article-title":"Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses","volume":"70","author":"Berry","year":"2002","journal-title":"Infect Immun"},{"issue":"7\u20138","key":"10.1016\/j.biologicals.2021.01.001_bib32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0264-410X(99)00276-5","article-title":"Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults","volume":"18","author":"Richmond","year":"1999","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biologicals.2021.01.001_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CVI.00009-07","article-title":"Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation","volume":"14","author":"Fusco","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.biologicals.2021.01.001_bib34","first-page":"586","article-title":"Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharide","volume":"12","author":"Giardina","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.biologicals.2021.01.001_bib36","series-title":"WHO Expert committee on biological standardization: sixty-first report","article-title":"Guidelines for independent lot release of vaccines by regulatory authorities","year":"2013"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105621000142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105621000142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:15:06Z","timestamp":1760922906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105621000142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":32,"alternative-id":["S1045105621000142"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2021.01.001","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Saccharide dosage content of meningococcal polysaccharide conjugate vaccines determined using WHO International Standards for serogroup A, C, W, Y and X polysaccharides","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2021.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.","name":"copyright","label":"Copyright"}]}}